Brief: Iconovo’S Partner Monash University Has Initiated A Phase I Clinical Trial On Inhaled Oxytocin In Icoone®
11/05/2023 08:23
Iconovo AB ICO.ST :
* ICONOVO’S PARTNER MONASH UNIVERSITY HAS INITIATED A PHASE
I
CLINICAL TRIAL ON INHALED OXYTOCIN IN ICOONE®
* ICONOVO AB - STUDY IS PART OF PREVIOUSLY ANNOUNCED
COLLABORATION
BETWEEN ICONOVO AND MONASH UNIVERSITY
* ICONOVO AB - PHASE I CLINICAL TRIAL AIMS TO INCLUDE 16
SUBJECTS
Source text for Eikon: ID:nMFN9c83qp
Further company coverage: ICO.ST